These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 17311509)
21. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study. Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874 [TBL] [Abstract][Full Text] [Related]
22. A Model Combining Testosterone, Androstenedione and Free Testosterone Index Improved the Diagnostic Efficiency of Polycystic Ovary Syndrome. Yi W; Zhang M; Yuan X; Shi L; Yuan X; Sun M; Liu J; Cai H; Lv Z Endocr Pract; 2023 Aug; 29(8):629-636. PubMed ID: 37225042 [TBL] [Abstract][Full Text] [Related]
23. Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome. Bui HN; Sluss PM; Hayes FJ; Blincko S; Knol DL; Blankenstein MA; Heijboer AC Clin Chim Acta; 2015 Oct; 450():227-32. PubMed ID: 26327459 [TBL] [Abstract][Full Text] [Related]
24. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome. Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651 [TBL] [Abstract][Full Text] [Related]
25. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943 [TBL] [Abstract][Full Text] [Related]
26. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome. Yasmin E; Balen AH; Barth JH Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586 [TBL] [Abstract][Full Text] [Related]
27. Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women. Willenberg HS; Bahlo M; Schott M; Wertenbruch T; Feldkamp J; Scherbaum WA Steroids; 2008 Jan; 73(1):41-6. PubMed ID: 17915271 [TBL] [Abstract][Full Text] [Related]
28. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
29. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria. Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857 [TBL] [Abstract][Full Text] [Related]
31. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Bizuneh AD; Joham AE; Teede H; Mousa A; Earnest A; Hawley JM; Smith L; Azziz R; Arlt W; Tay CT Hum Reprod Update; 2024 Sep; ():. PubMed ID: 39305127 [TBL] [Abstract][Full Text] [Related]
32. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women. El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085 [TBL] [Abstract][Full Text] [Related]
34. Serum HLA-G levels in women with polycystic ovary syndrome. Oztekin O; Fenkci SM; Fenkci V; Enli Y; Cabus U Gynecol Endocrinol; 2015 Mar; 31(3):243-6. PubMed ID: 25403326 [TBL] [Abstract][Full Text] [Related]
35. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538 [TBL] [Abstract][Full Text] [Related]
36. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550 [TBL] [Abstract][Full Text] [Related]
37. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576 [TBL] [Abstract][Full Text] [Related]
38. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome? Stener-Victorin E; Holm G; Labrie F; Nilsson L; Janson PO; Ohlsson C J Clin Endocrinol Metab; 2010 Feb; 95(2):810-9. PubMed ID: 20016048 [TBL] [Abstract][Full Text] [Related]
39. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. Timpatanapong P; Rojanasakul A J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062 [TBL] [Abstract][Full Text] [Related]
40. [Correlations between clinical signs and hormonal parameters in young women with hirsutism]. Kristesashvili J; Chanukvadze D Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]